期刊文献+

重组人白细胞介素10的临床研究进展

Current status of clinical trials for recombinant human interleukin 10
下载PDF
导出
摘要 白细胞介素10(IL-10)是人体多效细胞因子,在免疫系统中发挥着免疫抑制、抗炎及免疫调节的功能。就IL-10治疗银屑病、类风湿关节炎、克隆病、慢性丙型肝炎、器官移植等多种疾病的临床试验研究进展作一综述。 Interleukin 10 (IL-10) is a pleiotropic cytokine involved in immunosupression, antiinflammation and immuno-modulation. This paper reviews the progresses of clinical studies of recombinant human interleukin 10 for treatment of some diseases, such as psoriasis, rheumatoid arthri tis, Crohn' s disease, chronic hepatitis C and organ transplantation.
出处 《中国新药杂志》 CAS CSCD 北大核心 2005年第12期1403-1406,共4页 Chinese Journal of New Drugs
关键词 重组人白细胞介素10 免疫抑制 免疫调节 银屑病 类风湿关节炎 克隆病 recombinant interleukin 10 immunosupression immuno-modulation psoriasis rheumatoid arthritis Crohn' s disease
  • 相关文献

参考文献21

  • 1Conti P, Kempuraj D, Kandere K, et al. IL-10, an inflammatory/inhibitory cytokine, but not always[J]. Immunol Lett, 2003,86 (2) :123- 129. 被引量:1
  • 2Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy-review of a new approach [ J ]. Pharmacol Rev, 2003,55 ( 2 ) : 241 - 269. 被引量:1
  • 3Huhn RD, Radwanski E, Gallo J, et al. Pharmacodynamics of subcutaneous recombinant human interleukin-10 in healthy volunteers [J]. Clin Pharmacol Ther, 1997,62(2) : 171 - 180. 被引量:1
  • 4Schreiber S, Fedorak RN, Nielsen OH, et al. Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease[J]. Gastroenterology ,2000,119(6) : 1461 - 1472. 被引量:1
  • 5Rosenblum IY ,Johnson RC, Schmuhai TJ. Preclinical safety evaluation of recombinant human interleukin-10 [ J ]. Regul Toxicol Pharmacol,2002,35(1) :56 - 71. 被引量:1
  • 6Chakraborty A, Blum RA, Cutler DL, et al. Pharmacoimmunodynamic interactions of interleukin-10 and prednisone in healthy volunteers[J]. Clin Pharmacol Ther, 1999,65(3) :304 - 318. 被引量:1
  • 7Radwanski E, Chakraborty A, Van Wart S, et al. Pharmacokinetics and leukocyte responses of recombinant human interleukin-10 [J].Pharm Res, 1998,15(12) : 1895 - 1901. 被引量:1
  • 8Kimball AB, Kawamura T, Tejura K, et al. Clinical and immunologic assessment of patients with psoriasis in a randomized, dnuble-blind, placebo-controlled trial using recombinant human interleukin 10[J].Arch Dermatol,2002,138(10) : 1341 - 1346. 被引量:1
  • 9Asadullah K, Sterry W, Stephanek K, et al. IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapentic approach[ J]. J Clin Invest, 1998,101(4) :783 - 794. 被引量:1
  • 10Reich K, Bruck M, Grafe A, et al. Treatment of psoriasis with interleukin-10[J]. J Invest Dermatol, 1998,111 (6) : 1235 - 1236. 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部